Loading...
•
Mar 31, 2021
Beauty Health Q1 2021 Earnings Report
Reported record first quarter results and updated fiscal 2021 outlook.
Key Takeaways
The Beauty Health Company reported a strong first quarter with net sales of $47.5 million, a 46% increase year-over-year. The company's performance was driven by strong sales in both delivery systems and consumables, and they have updated their top-line guidance for 2021 to approximately $200 million.
Q1 net sales reached $47.5 million, up 46% from Q1 2020.
Delivery system sales increased to $25.6 million, compared to $14.1 million in Q1 2020.
Consumables sales increased to $21.9 million, compared to $18.5 million in Q1 2020.
Q1 operating income was $2.4 million, a significant improvement from the $7.3 million operating loss in Q1 2020.
Beauty Health
Beauty Health
Beauty Health Revenue by Segment
Beauty Health Revenue by Geographic Location
Revenue by Segment
Delivery Systems Revenue
CapyFin.comConsumables Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comAPAC Revenue
CapyFin.comEMEA Revenue
CapyFin.com Forward Guidance
For fiscal year 2021, the company expects net sales of approximately $200 million, adjusted EBITDA of approximately $25 million, and up to $15 million in capital expenditures.
Positive Outlook
- Net sales of approximately $200 million.
- Adjusted EBITDA of approximately $25 million.
- Up to $15 million of capital expenditures.
- Expected results from the anticipated acquisition of certain distributors in the first half of 2021.
- Assumes a largely reopened global market.
Challenges Ahead
- Subject to risks and uncertainties disclosed in filings with the Securities and Exchange Commission.
- Does not take into account the impact of any unanticipated developments in our business or changes in our operating environment.
- Does not take into account any unannounced acquisitions, dispositions or unannounced financings during 2021.
- Potential risk for further market closures from new COVID-19 strains.
- Uneven global rollout of the vaccines.
Revenue & Expenses
Visualization of income flow from segment revenue to net income